A last resort in invasive aspergillosis

Prescrire International

Volumn 11, Issue 61, 2002, Pages 142-143

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; CYCLOSPORIN; CYTOCHROME P450; FLUCONAZOLE; HISTAMINE; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RIFAMPICIN; TACROLIMUS; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MYCOPHENOLIC ACID; PEPTIDE;

ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CROSS REACTION; DOSE RESPONSE; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVITY; EUROPEAN UNION; FATALITY; FEVER; HEADACHE; HISTAMINE RELEASE; HUMAN; IMMUNE DEFICIENCY; INJECTION SITE; LIVER DISEASE; LUNG ASPERGILLOSIS; NAUSEA; NONHUMAN; PROSPECTIVE STUDY; RASH; RELAPSE; SKIN MANIFESTATION; SURVIVAL; ASPERGILLOSIS; COMPARATIVE STUDY; DRUG INTERACTION; FRANCE; LUNG MYCOSIS; TREATMENT OUTCOME;

AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CLINICAL TRIALS; DRUG APPROVAL; DRUG INTERACTIONS; FRANCE; HUMANS; ITRACONAZOLE; LUNG DISEASES, FUNGAL; MYCOPHENOLIC ACID; PEPTIDES; TREATMENT OUTCOME;

EID: 0036781943     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Hoang AT "Caspofungin acetate: an antifungal agent" Am J Health Syst Pharm 2001; 58: 1206-1214.
2. Bennett JE "Aspergillosis". In: Braunwald E et al. "Harrison's principles of internal medicine" 15th ed., McGraw-Hill, New York 2001: 1178-1179.
3. Stevens DA et al. "Practice guidelines for diseases caused by Aspergillus" Clin Infect Dis 2000; 30: 696-709.
4. FDA Advisory committee meeting background "Caspofugin acetate" 6 December 2000: 180 pages.
5. Prescrire Rédaction "amphotéricine B liposomale-Ambisome°" Rev Prescr 1999; 19 (200): 745.
6. The European Agency for the Evaluation of Medicinal Products - Committee for Proprietary Medicinal Products - European Public Assessment Report "caspofungin". London 7 November 2001: 87 pages.
7. Merck Research Laboratories slides for oral presentation "Antiviral drugs advisory committee meeting" Food and Drug Administration" 10 January 2001: 20 pages.